Vitls
Houston, US · Founded 2016 · Delaware corporation
Find your way into Vitls
Sign up to see every warm intro you have to Vitls
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Vitls team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
GM
Gregory MossNamed on SEC filing
WV
Werner VorsterNamed on SEC filing
LV
Louise VorsterNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$7.2M disclosed across 4 rounds · 2017–2022
▶$1.3MraisedNov 2022 · 9 investors · BiotechnologyRule 506(b)
▶$1.3MraisedNov 2022 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Cadell LiedtkeDirector
- Greg MossDirector
- Louise VorsterExecutive Officer, Director
- Greg CampbellDirector
- Werner VorsterExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.3M
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.5MraisedNov 2021 · 24 investors · BiotechnologyRule 506(b)
▶$4.5MraisedNov 2021 · 24 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Werner VorsterExecutive Officer, Director
- Greg CampbellDirector
- Greg MossDirector
- Louise VorsterExecutive Officer, Director
- Cadell LiedtkeDirector
- Offering amount
- $5.3M
- Amount sold
- $4.5M
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$385KraisedDec 2018 · 7 investors · BiotechnologyRule 506(b)
▶$385KraisedDec 2018 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Louise VorsterExecutive Officer, Director
- Gregory MossDirector
- Werner VorsterExecutive Officer, Director
- Offering amount
- $385K
- Amount sold
- $385K
- Minimum investment
- $10K
- First sale
- May 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$1.1MraisedAug 2018 · 11 investors · BiotechnologyRule 506(b)
▶$1.1MraisedAug 2018 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gregory MossDirector
- Werner VorsterExecutive Officer, Director
- Louise VorsterExecutive Officer, Director
- Offering amount
- $1.1M
- Amount sold
- $1.1M
- Minimum investment
- $10K
- Proceeds to insiders
- $180K
- First sale
- Jul 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Vitls raised?
- Vitls has disclosed $7.2M raised across 4 rounds.
- Where is Vitls headquartered?
- Vitls is headquartered in Houston, US.